Aman Clinics Partners with Cenegenics for Precision Medicine Program in Qatar
Aman Clinics has partnered with Cenegenics to launch a precision medicine and longevity program in Doha, Qatar. The new service focuses on personalized health optimization and proactive aging.
Doha, Qatar – Aman Clinics, a subsidiary of Aman Hospital, has announced a strategic partnership with Cenegenics to launch the Cenegenics Precision Medicine & Longevity Program in Doha. This initiative marks the introduction of a data-driven approach to health optimization and proactive aging in the region.
The program centers on a clinical model utilizing advanced testing, genomic profiling, and biomarker evaluation. Instead of using one-size-fits-all recommendations, Cenegenics develops personalized plans based on comprehensive genomic and biological blueprints. The service assesses metabolic function, cardiovascular risk, hormone balance, body composition, nutrition, cognitive performance, sleep, and lifestyle factors.
Graham Galka, CEO of Cenegenics, stated that the partnership brings their model to a region known for innovation and high standards of care. He anticipates the collaboration will establish a new benchmark for preventive healthcare.
Aman Clinics continues its mission to introduce global healthcare innovations to the local market. This partnership with Cenegenics aligns with a broader strategy to advance proactive medicine and empower individuals to make informed decisions about their long-term health and well-being.